
Recirculating hollow fiber systems have been used for a long time with mixed results. The recurring problem with these and all other cell retention systems is the difficulty in scaling up and staying sterile. Many cell retention systems scale up based upon surface area, or a separation chamber of sorts, that upon transfer into a manufacturing environment become very challenging to run efficiently or reliably. Many companies who use internal spin filters or centrifuges, for example, typically invest a considerable amount of time optimizing their often unique installations.
Trying to avoid cell damage or time outside of the reactor in a dead zone are common issues with those systems. These problems are eliminated when the ATF™ System is used as a production platform. The ATF System scales nearly linearly and is simple and quick to install, operate, validate and maintain. With the ATF System process development becomes simple since there is little equipment optimization required so all time can be spent improving media and bioreactor conditions. The ATF System allows significant cell density to be achieved rapidly.
Key benefits include:
Some cell lines show a decrease in cell size, allowing a faster molecular transfer across the cell wall (increase of surface area to volume ratio). Together these benefits deliver high viability and higher growth rate and thereby lead to a surprising high cell concentration in almost every cell line tested.
Perfusion had become regarded as a process option to be used when the stability of the protein is low or if the expression of the cell-line is minimal such that a constant output becomes more economic. Perfusion has suffered from complex or unreliable equipment diminishing its attractiveness, and attracted a perception that process development or operation is difficult.
No longer, you’ll be glad to know! The ATF System solves all these problems and make the process as simple as - some would say simpler than - fed-batch processes.

The death of perfusion has always been more of a marketing success than anything else. Several blockbuster and medium size marketed drugs are made today in perfusion processes – and more are planned. Today however, perfusion is very much on the rise with the ATF System leading the way. So what is concentrated perfusion and how it can improve on the existing perfusion methods?
Key benefits include:
Feb
27
February 27 - February 29, 2012
4th Annual Disposable Solutions for Biomanufacturing
Brussels
Apr
02
April 02 - April 04, 2012
ISBioTech 2nd Annual Meeting
Virginia
Apr
11
April 11 - April 13, 2012
World Vaccine Congress 2012
Washington
Apr
18
April 18 - April 19, 2012
BioProcess International Europe 2012
Prague